Keywords
Oral treatment
Adverse reactions
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To present the studies already produced in relation to the main reasons that influence adherence and non-adherence to treatment with oral antineoplastics, investigating the barriers and facilitators related to the disease and its treatment. Methods: This is an Integrative Review of the literature, with articles published between January 2013 and June 2023, with full text available. The following guiding questions were used: “Main reasons that contribute to non-adherence to oral therapy” and “Opportunities to improve adherence to oral therapy”. The bibliographic research was carried out in the months of May and June 2023, with searches being carried out in the Pubmed database, using the descriptors: "oral chemotherapy" and "adherence", the process of selecting works for this article was carried out through independent peer review. Results: The search resulted in 14 articles that met the inclusion and exclusion criteria. Final considerations: The main facilitators of adherence to treatment were the level of information patients had about their treatment, multidisciplinary monitoring and the main barriers to non-adherence were forgetfulness and adverse reactions to the medication.
References
BARILLET M, et al. Oral antineoplastic agents: how do we care about adherence? Br J Clin Pharmacol.
CARVALHO MS, et al. Comitê de publicações em estudo multicêntrico e sistema informatizado de apoio - publiELSA. Rev Saúde Pública. 2013; 47: 48–53.
DAVIS TC, et al. Assessment of Oral Chemotherapy Nonadherence in Chronic Myeloid Leukemia Patients Using Brief Measures in Community Cancer Clinics: A Pilot Study. Int J Environ Res Public Health. 2021; 18(21): 11045.
DENNISON T, et al. A Pharmacist-Led Oral Chemotherapy Program's Impact on Chronic Myeloid Leukemia Patient Satisfaction, Adherence, and Outcomes. J Adv Pract Oncol. 2021; 12(2): 148-157.
ENGLE JA, et al. Assessment of adherence and relative dose intensity with oral chemotherapy in oncology clinical trials at an academic medical center. J Oncol Pharm Pract. 2018; 24(5): 348-353.
GEBBIA V, et al. Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents. 2012; 11(1): S49-59.
GHIGGIA A, et al. Adherence to oral chemotherapy: Evidence from a randomised clinical trial. Eur J Cancer Care (Engl). 2021; 30(1): 13336.
GÖNDEREN ÇHS e UNCU D. Relationship between Health Literacy and Medication Adherence of Turkish Cancer Patients Receiving Oral Chemotherapy. Asia Pac J Oncol Nurs. 2020; 7(4): 365-369.
GIL C. Como elaborar projetos de pesquisa. São Paulo: Atlas; 2017; 6.
HEFNER J, et al. Patient-doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center. Patient Prefer Adherence. 2018; 12:1 875-1887.
ISAAC EI,et al. Longitudinal Patterns of Social Problem-Solving Skills in an Ethnically Diverse Sample of Pediatric Patients with Cancer and their Caregivers. Int J Environ Res Public Health. 2020; 17(5): 1581.
ISAAC EI, et al. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life. J Natl Compr Canc Netw. 2019; 17(3): 221-228.
LEA CS, et al. Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting. BMC Res Notes. 2018; 11(1): 843.
MCGRADY ME, et al. Medication adherence decision-making among adolescents and young adults with cancer. Eur J Oncol Nurs. 2016; 20: 207-14.
NEDEL WL e SILVEIRA FDA. Os diferentes delineamentos de pesquisa e suas particularidades na terapia intensiva. Rev bras ter intensiva. Associação de Medicina Intensiva Brasileira - AMIB; 2016; 28(3): 256–260.
OLIVEIRA FR, et al. Adherencia a tratamientos antineoplásicos orales.Farm. hosp, 2014; 38(6): 475-481.
PATEL K, et al. Oral cancer chemotherapy adherence and adherence assessment tools: a report from North Central Cancer Group Trial N0747 and a systematic review of the literature. J Cancer Educ. 2013; 28(4): 770-6.
REGNIER DV, et al. Adesão à quimioterapia oral: Resultados de um estudo qualitativo do comportamento e representações de pacientes e oncologistas. EUR. J. Cancer Care. 2011; 20: 520–527.
SABATE E. Adherence to long-term therapies: evidence for action. World Health Organization (WHO), 2013.
STOKES M, et al. Impact of pharmacy channel on adherence to oral oncolytics. BMC Health Serv Res. 2017; 17(1): 414.
SUGISAKA ACA, et al. Validação de Materiais Educativos para Orientação de Pacientes em Tratamento de Câncer de Mama com Hormonioterapia. Rev Bras Cancerol, 2020; 66(4): 051079.
SCHNEIDER SM, et al. A tailored nurse coaching intervention for oral chemotherapy adherence. J Adv Pract Oncol. 2014; 5(3): 163-72.
SIMONS S, et al. Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support Care Cancer. 2011; 19(7): 1009-18.
TALENS A, et al. Medication Experience and Adherence to Oral Chemotherapy: A Qualitative Study of Patients' and Health Professionals' Perspectives. Int J Environ Res Public Health. 2021;1 8(8): 4266.
VERBRUGGHE M, et al. Fatores que influenciam a adesão em pacientes com câncer que tomam inibidores orais de tirosina quinase. Enfermeiras do Câncer. 2016; 39: 153–162.
XAVIER FD, et al. Treatment of elderly patients with refractory/relapsed multiple myeloma: oral drugs adherence and the COVID-19 outbreak. Oncotarget. 2020; 11(47): 4371-4386.